Proteasomal	JJ	proteasomal JJ PennPOS
regulation	NN	regulation NN PennPOS
of	IN	of pp-f NUPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
.	.	. . NUPOS

It	PRP	it pn31 NUPOS
is	VBZ	be vbz NUPOS
estimated	VBN	estimate VBN PennPOS
that	IN	that cst NUPOS
,	,	, , NUPOS
combined	VBN	combine VBN PennPOS
,	,	, , NUPOS
400,000	CD	400,000 crd NUPOS
people	NNS	people n2 NUPOS
are	VBP	be vbb NUPOS
diagnosed	VBN	diagnose VBN PennPOS
with	IN	with pp NUPOS
idiopathic	JJ	idiopathic JJ PennPOS
pulmonary	JJ	pulmonary JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
(	(	( ( NUPOS
IPF	NN	IPF NN PennPOS
)	)	) ) NUPOS
or	CC	or cc NUPOS
acute	JJ	acute JJ PennPOS
lung	NN	lung NN PennPOS
injury/acute	NN	injury/acute NN PennPOS
respiratory	JJ	respiratory JJ PennPOS
distress	NN	distress NN PennPOS
syndrome	NN	syndrome NN PennPOS
annually	RB	annual av-j NUPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
United	NNP	United NNP PennPOS
States	NNPS	state NNS PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
both	DT	both d NUPOS
diseases	NNS	disease NNS PennPOS
are	VBP	be vbb NUPOS
associated	VBN	associate VBN PennPOS
with	IN	with pp NUPOS
an	DT	a dt NUPOS
unacceptably	RB	unacceptable RB PennPOS
high	JJ	high JJ PennPOS
mortality	NN	mortality NN PennPOS
rate	NN	rate NN PennPOS
.	.	. . NUPOS

Although	IN	although cs NUPOS
these	DT	these d NUPOS
disorders	NNS	disorder NNS PennPOS
are	VBP	be vbb NUPOS
distinct	JJ	distinct JJ PennPOS
clinical	JJ	clinical JJ PennPOS
entities	NNS	entity NNS PennPOS
,	,	, , NUPOS
they	PRP	they pns31 NUPOS
share	VBP	share VBP PennPOS
pathogenic	JJ	pathogenic JJ PennPOS
mechanisms	NNS	mechanism NNS PennPOS
that	WDT	that WDT PennPOS
may	MD	may vmb NUPOS
provide	VB	provide VBP PennPOS
overlapping	VBG	overlap VBG PennPOS
therapeutic	JJ	therapeutic JJ PennPOS
targets	NNS	target NNS PennPOS
.	.	. . NUPOS

One	CD	one crd NUPOS
example	NN	example NN PennPOS
is	VBZ	be vbz NUPOS
fibroblast	NN	fibroblast NN PennPOS
activation	NN	activation NN PennPOS
,	,	, , NUPOS
which	WDT	which r-crq NUPOS
occurs	VBZ	occur VBZ PennPOS
concomitant	JJ	concomitant JJ PennPOS
with	IN	with pp NUPOS
acute	JJ	acute JJ PennPOS
lung	NN	lung NN PennPOS
injury	NN	injury NN PennPOS
as	RB	as a-acp NUPOS
well	RB	well av NUPOS
as	IN	as c-acp NUPOS
in	IN	in IN PennPOS
the	DT	the dt NUPOS
progressive	JJ	progressive JJ PennPOS
fibrosis	NN	fibrosis NN PennPOS
of	IN	of pp-f NUPOS
IPF	NN	IPF NN PennPOS
.	.	. . NUPOS

Both	DT	both d NUPOS
clinical	JJ	clinical JJ PennPOS
entities	NNS	entity NNS PennPOS
are	VBP	be vbb NUPOS
characterized	VBN	characterize VBN PennPOS
by	IN	by IN PennPOS
elevations	NNS	elevation NNS PennPOS
of	IN	of pp-f NUPOS
the	DT	the dt NUPOS
profibrotic	JJ	profibrotic JJ PennPOS
cytokine	NN	cytokine NN PennPOS
,	,	, , NUPOS
transforming	VBG	transform VBG PennPOS
growth	NN	growth NN PennPOS
factor	NN	factor NN PennPOS
(	(	( ( NUPOS
TGF	NN	tgf NN PennPOS
)	)	) ) NUPOS
-	:	- : NUPOS
beta1	NN	beta1 NN PennPOS
.	.	. . NUPOS

Protein	NN	protein NN PennPOS
degradation	NN	degradation NN PennPOS
by	IN	by IN PennPOS
the	DT	the dt NUPOS
ubiquitin-proteasomal	JJ	ubiquitin-proteasomal JJ PennPOS
system	NN	system NN PennPOS
modulates	VBZ	modulate VBZ PennPOS
TGF-beta1	NN	TGF-beta1 NN PennPOS
expression	NN	expression NN PennPOS
and	CC	and cc NUPOS
signaling	NN	signaling NN PennPOS
.	.	. . NUPOS

In	IN	in IN PennPOS
this	DT	this d NUPOS
review	NN	review NN PennPOS
,	,	, , NUPOS
we	PRP	we pns12 NUPOS
highlight	VBP	highlight VBP PennPOS
the	DT	the dt NUPOS
effects	NNS	effect NNS PennPOS
of	IN	of pp-f NUPOS
proteasomal	JJ	proteasomal JJ PennPOS
inhibition	NN	inhibition NN PennPOS
in	IN	in IN PennPOS
various	JJ	various JJ PennPOS
animal	NN	animal NN PennPOS
models	NNS	model NNS PennPOS
of	IN	of pp-f NUPOS
tissue	NN	tissue NN PennPOS
fibrosis	NN	fibrosis NN PennPOS
and	CC	and cc NUPOS
mechanisms	NNS	mechanism NNS PennPOS
by	IN	by IN PennPOS
which	WDT	which r-crq NUPOS
it	PRP	it pn31 NUPOS
may	MD	may vmb NUPOS
regulate	VB	regulate VBP PennPOS
TGF-beta1	NN	TGF-beta1 NN PennPOS
expression	NN	expression NN PennPOS
and	CC	and cc NUPOS
signaling	NN	signaling NN PennPOS
.	.	. . NUPOS

At	IN	at pp NUPOS
present	JJ	present JJ PennPOS
,	,	, , NUPOS
there	EX	there pc-acp NUPOS
are	VBP	be vbb NUPOS
no	DT	no dx NUPOS
effective	JJ	effective JJ PennPOS
therapies	NNS	therapy NNS PennPOS
for	IN	for c-acp NUPOS
fibroproliferative	JJ	fibroproliferative JJ PennPOS
acute	JJ	acute JJ PennPOS
respiratory	JJ	respiratory JJ PennPOS
distress	NN	distress NN PennPOS
syndrome	NN	syndrome NN PennPOS
or	CC	or cc NUPOS
IPF	NN	IPF NN PennPOS
,	,	, , NUPOS
and	CC	and cc NUPOS
proteasomal	JJ	proteasomal JJ PennPOS
inhibition	NN	inhibition NN PennPOS
may	MD	may vmb NUPOS
provide	VB	provide VBP PennPOS
a	DT	a dt NUPOS
novel	JJ	novel JJ PennPOS
,	,	, , NUPOS
attractive	JJ	attractive JJ PennPOS
target	NN	target NN PennPOS
in	IN	in IN PennPOS
these	DT	these d NUPOS
devastating	JJ	devastating JJ PennPOS
diseases	NNS	disease NNS PennPOS
.	.	. . NUPOS

